We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
The biologics market is growing rapidly, unlocking exciting opportunities while also introducing significant challenges. Developers are undergoing pressure to deliver innovative therapies quickly, all while navigating complex regulatory requirements, challenging clinical trial phases, scaling production efficiently, and ensuring consistent quality.
In a recent webinar, Thermo Fisher Scientific’s industry experts shared practical strategies and real-world examples to help you address these challenges. As a trusted CDMO and CRO partner, we are here to support the success of your biologics program in today’s dynamic market. Explore three key takeaways from this on-demand webinar below:
Key takeaways: